Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies.
Soldierer M, Bister A, Haist C, Thivakaran A, Cengiz SC, Sendker S, Bartels N, Thomitzek A, Smorra D, Hejazi M, Uhrberg M, Scheckenbach K, Monzel C, Wiek C, Reinhardt D, Niktoreh N, Hanenberg H. Soldierer M, et al. Among authors: bister a. Front Immunol. 2022 Apr 7;13:847008. doi: 10.3389/fimmu.2022.847008. eCollection 2022. Front Immunol. 2022. PMID: 35464442 Free PMC article.
Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells.
Grunewald CM, Haist C, König C, Petzsch P, Bister A, Nößner E, Wiek C, Scheckenbach K, Köhrer K, Niegisch G, Hanenberg H, Hoffmann MJ. Grunewald CM, et al. Among authors: bister a. Front Immunol. 2021 Nov 17;12:782448. doi: 10.3389/fimmu.2021.782448. eCollection 2021. Front Immunol. 2021. PMID: 34868059 Free PMC article.
Profiling the 3D interaction between germ cell tumors and microenvironmental cells at the transcriptome and secretome level.
Skowron MA, Eul K, Stephan A, Ludwig GF, Wakileh GA, Bister A, Söhngen C, Raba K, Petzsch P, Poschmann G, Kuffour EO, Degrandi D, Ali S, Wiek C, Hanenberg H, Münk C, Stühler K, Köhrer K, Mass E, Nettersheim D. Skowron MA, et al. Among authors: bister a. Mol Oncol. 2022 Sep;16(17):3107-3127. doi: 10.1002/1878-0261.13282. Epub 2022 Jul 26. Mol Oncol. 2022. PMID: 35811571 Free PMC article.
Author Correction: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma.
Ryl T, Afanasyeva E, Hartmann T, Schwermer M, Schneider M, Schröder C, Wagemanns M, Bister A, Kanber D, Steenpass L, Schramm K, Jones B, Jones DTW, Biewald E, Astrahantseff K, Hanenberg H, Rahmann S, Lohmann DR, Schramm A, Ketteler P. Ryl T, et al. Among authors: bister a. Commun Biol. 2024 Sep 11;7(1):1119. doi: 10.1038/s42003-024-06830-1. Commun Biol. 2024. PMID: 39261566 Free PMC article. No abstract available.
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma.
Ryl T, Afanasyeva E, Hartmann T, Schwermer M, Schneider M, Schröder C, Wagemanns M, Bister A, Kanber D, Steenpass L, Schramm K, Jones B, Jones DTW, Biewald E, Astrahantseff K, Hanenberg H, Rahmann S, Lohmann DR, Schramm A, Ketteler P. Ryl T, et al. Among authors: bister a. Commun Biol. 2024 Jul 30;7(1):919. doi: 10.1038/s42003-024-06596-6. Commun Biol. 2024. PMID: 39079981 Free PMC article.
12 results